Bio-Path Holdings competitorsClear all
Bio-Path Holdings's top competitors include Vivace Therapeutics, MiracleCord, Corcept Therapeutics and Delcath Systems.
| Save Comparison |  Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. |  Corcept Therapeutics Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders. |  Delcath Systems Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology. | ||
Founding Date | Founding Date 2007 | Founding Date 2014 | Founding Date 1997 | Founding Date 1998 | Founding Date 1988 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Bellaire, US HQ | Locations HQ | Locations Chicago, US HQ | Locations Menlo Park, US HQ | Locations New York, US HQ Galway, IE Queensbury, US |
Employees | Employees 811% decrease | Employees 7 | Employees 1 | Employees 16622% increase | Employees 437% decrease |
Valuation ($) | Valuation ($) 66.3 k | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 1 m |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers 79 | Twitter followers 117 | Twitter followers 487 |
Alexa Website Rank | Alexa Website Rank 1520286 | Alexa Website Rank 331316 | Alexa Website Rank 872749 | Alexa Website Rank 1121653 | Alexa Website Rank 894835 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.4m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $5.2m (FY, 2018) | Cost of goods $1m (FY, 2018) |
Net income | Net income ($8.6m) (FY, 2018) | Net income N/A | Net income N/A | Net income $75.4m (FY, 2018) | Net income ($19.2m) (FY, 2018) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 25m (about 2 years ago) | Latest funding round $ 200k (over 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 2.3m | Total funding raised $ 40m | Total funding raised $ 200k | Total funding raised $ 80.1m | Total funding raised $ 42m |
For sources of this data, please see the company profile
View company profiles
MiracleCord
HQ
Chicago, US
Employees
1
MiracleCord provides baby cord blood banking services.
View companyCorcept Therapeutics
HQ
Menlo Park, US
Employees
166↑ 22% increase
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
View companyDelcath Systems
HQ
New York, US
Employees
43↓ 7% decrease
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
View company